UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Rehabilitation von Arm-Hand-Paresen nach Schlaganfall: Zwei Fallbeispiele

Psychopraxis neuropraxis, 2022-06, Vol.25 (3), p.134-140

Fheodoroff, Klemens

2022

Volltextzugriff (PDF)

Modelling Long-Term Outcomes for BoNT-A in Patients With Post-Stroke Spasticity

Toxicon (Oxford), 2024-01, Vol.237, p.107400, Article 107400

Fheodoroff, Klemens

2024

Volltextzugriff (PDF)

Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study

Journal of rehabilitation medicine, 2021-02, Vol.53 (2), p.jrm00157

2021

Volltextzugriff (PDF)

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity

Journal of Neural Transmission, 2021-03, Vol.128 (3), p.321-335

2021

Volltextzugriff (PDF)

Modelling Long-Term Outcomes and Risk of Death for Patients with Post-Stroke Spasticity Receiving Abobotulinumtoxina Treatment and Rehabilitation Therapy

Journal of rehabilitation medicine, 2022-08, Vol.54, p.jrm00303-jrm00303

2022

Volltextzugriff (PDF)

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part I Development and responsiveness

Journal of rehabilitation medicine, 2022, Vol.54, p.jrm00244-jrm00244

2022

Volltextzugriff (PDF)

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis

Toxins, 2023-12, Vol.16 (1), p.19

2023

Volltextzugriff (PDF)

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part II A first psychometric evaluation

Journal of rehabilitation medicine, 2022, Vol.54, p.jrm00243-jrm00243

2022

Volltextzugriff (PDF)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

Health and quality of life outcomes, 2020-03, Vol.18 (1), p.51-51, Article 51

2020

Volltextzugriff (PDF)

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment

Frontiers in neurology, 2020-02, Vol.11, p.104-104

2020

Volltextzugriff (PDF)

Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study

Journal of rehabilitation medicine, 2021-01, Vol.53 (1), p.jrm00133

2021

Volltextzugriff (PDF)

Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology

Neurological research and practice, 2021-05, Vol.3 (1), p.23-23, Article 23

2021

Volltextzugriff (PDF)

Efficacy of Four-Channel Functional Electrical Stimulation on Moderate Arm Paresis in Subacute Stroke Patients-Results from a Randomized Controlled Trial

Healthcare (Basel), 2022-04, Vol.10 (4), p.704

2022

Volltextzugriff (PDF)

Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands

Orphanet journal of rare diseases, 2020-03, Vol.15 (1), p.64-64, Article 64

2020

Volltextzugriff (PDF)

Healthcare needs, expectations, utilization, and experienced treatment effects in patients with hereditary spastic paraplegia: a web-based survey in the Netherlands

Orphanet journal of rare diseases, 2021-06, Vol.16 (1), p.1-283, Article 283

2021

Volltextzugriff (PDF)

Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study

Toxins, 2015-04, Vol.7 (4), p.1192-1205

2015

Volltextzugriff (PDF)

Initial Assessment of the Validity and Inter-Rater Reliability For Early Recognition of Spasticity Using the Decision Tree Tool (I-REFER)

Toxicon (Oxford), 2024-01, Vol.237, p.107399, Article 107399

2024

Volltextzugriff (PDF)

Do we have the right goals for spasticity patients?

Toxicon (Oxford), 2018-12, Vol.156, p.S33-S33

2018

Volltextzugriff (PDF)

ULIS (Upper Limb International Spasticity), a 10-year Odyssey: An international, multicentric, longitudinal cohort of person-centered spasticity management in real-life practice

Journal of the International Society of Physical and Rehabilitation Medicine, 2019-01, Vol.2 (3), p.138-150

2019

Volltextzugriff (PDF)

Poster 373-C Integrated Upper Limb Spasticity Management Including Botulinum Toxin A (BoNT-A) on Patient-Centered Goal Attainment: Methodology for ULIS-III and Initial Goal-Setting Data

PM & R, 2016-09, Vol.8 (9), p.S331-S331

2016

Volltextzugriff (PDF)

Poster 313 Relationship Between AbobotulinumtoxinA Injections into Shoulder Muscles and Patient Centred Primary Goal Selection and Achievement: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study

PM & R, 2016-09, Vol.8 (9), p.S262-S262

2016

Volltextzugriff (PDF)

Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study

Disability and rehabilitation, 2022-04, Vol.44 (8), p.1367-1373

2022

Volltextzugriff (PDF)

Upper Limb International Spasticity Study-II (ULIS-II): Results of a Large, International, Prospective Cohort Study Investigating Practice and Goal Attainment Following Treatment With Botulinum Toxin A in Real-Life Clinical Management

PM & R, 2013-09, Vol.5 (9), p.S238-S239

2013

Volltextzugriff (PDF)

Outcomes Related to Pain in a Cohort of Patients Treated with Botulinum Toxin A (BoNT-A) for Post-Stroke Upper Limb Spasticity - ULIS II Study

PM & R, 2013-09, Vol.5 (9), p.S243-S243

2013

Volltextzugriff (PDF)

Outcomes Related to Active Function in a Cohort of Patients Treated With Botulinum Toxin A (Bont-A) for Post-Stroke Upper Limb Spasticity - ULIS II Study

PM & R, 2013-09, Vol.5 (9), p.S240-S240

2013

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(77)
Buchkapitel
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(20)
Spasticity
(19)
Rehabilitation
(17)
Botulinum Toxin
(13)
Muscle Spasticity - Drug Therapy
(11)
Botulinum Toxins, Type A - Therapeutic Use
(9)
Patients
(9)
Stroke
(9)
Adult
(7)
Physical Medicine And Rehabilitation
(7)
Female
(6)
Male
(6)
Pain
(6)
Prospective Studies
(6)
Quality Of Life
(6)
Sport Sciences
(6)
Chronic Illnesses
(5)
Employment
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rehabilitation von Arm-Hand-Paresen nach Schlaganfall: Zwei Fallbeispiele

Modelling Long-Term Outcomes for BoNT-A in Patients With Post-Stroke Spasticity

Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity

Modelling Long-Term Outcomes and Risk of Death for Patients with Post-Stroke Spasticity Receiving Abobotulinumtoxina Treatment and Rehabilitation Therapy

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part I Development and responsiveness

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis

The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part II A first psychometric evaluation

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment

Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study

Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology

Efficacy of Four-Channel Functional Electrical Stimulation on Moderate Arm Paresis in Subacute Stroke Patients-Results from a Randomized Controlled Trial

Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands

Healthcare needs, expectations, utilization, and experienced treatment effects in patients with hereditary spastic paraplegia: a web-based survey in the Netherlands

Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study

Initial Assessment of the Validity and Inter-Rater Reliability For Early Recognition of Spasticity Using the Decision Tree Tool (I-REFER)

Do we have the right goals for spasticity patients?

ULIS (Upper Limb International Spasticity), a 10-year Odyssey: An international, multicentric, longitudinal cohort of person-centered spasticity management in real-life practice

Poster 373-C Integrated Upper Limb Spasticity Management Including Botulinum Toxin A (BoNT-A) on Patient-Centered Goal Attainment: Methodology for ULIS-III and Initial Goal-Setting Data

Poster 313 Relationship Between AbobotulinumtoxinA Injections into Shoulder Muscles and Patient Centred Primary Goal Selection and Achievement: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study

Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study

Upper Limb International Spasticity Study-II (ULIS-II): Results of a Large, International, Prospective Cohort Study Investigating Practice and Goal Attainment Following Treatment With Botulinum Toxin A in Real-Life Clinical Management

Outcomes Related to Pain in a Cohort of Patients Treated with Botulinum Toxin A (BoNT-A) for Post-Stroke Upper Limb Spasticity - ULIS II Study

Outcomes Related to Active Function in a Cohort of Patients Treated With Botulinum Toxin A (Bont-A) for Post-Stroke Upper Limb Spasticity - ULIS II Study

Suchergebnisse filtern